Search

Search Constraints

You searched for: Author/Creator Lund, Lars H.

Search Results

151. Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score. (3rd March 2021)

152. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology. (18th September 2017)

153. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology. (18th September 2017)

154. Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM‐HF trial, ESC guidelines, and real world. (18th June 2019)

155. Screening for heart transplantation and left ventricular assist system: results from the ScrEEning for advanced Heart Failure treatment (SEE‐HF) study. (27th September 2017)

156. Self‐care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology. (20th October 2020)

157. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry. (20th December 2019)

158. Sex‐related differences in left ventricular assist device utilization and outcomes: results from the PCHF‐VAD registry. (22nd December 2022)

159. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study. (June 2017)

160. Spinal cord stimulation in heart failure: effect on disease‐associated biomarkers. (3rd February 2017)